Nong Xu - Zhejiang University School of Medicine

基本信息

Career Trajectory

Bio

浙江大学医学院硕士毕业。从事肿瘤内科临床研究29年。曾在浙江省肿瘤工作16年，2001年调至浙医一院并组建化疗科。1999年在澳大利亚布里斯班Mater医院接受肿瘤学职业培训和临床进修。2002年在上海复旦大学接受全国GCP培训获临床试验资格证书。2005年ASCO Multidisciplinary Cancer Management Course（MCMC）培训，中国西安。

Research Interests

Papers共 311 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The Molecular Subtyping and Precision Medicine in Triple-Negative Breast Cancer---based on Fudan TNBC Classification

Lijuan Weng,Jianliang Zhou,Shenchao Guo,Nong Xu,Ruishuang Ma

Cancer Cell Internationalno. 1 (2025): 1-1

Cited3Views0WOSBibtex

Blood Biomarker-Based Predictive Indicator for Liver Metastasis in Alpha-Fetoprotein-Producing Gastric Cancer and Multi-Omics Tumor Microenvironment Insights

Yongfeng Ding, Yiran Chen,Jing Zhang, Qingrui Wang, Songting Zhu, Junjie Jiang,Chao He, Jincheng Wang,Laizhen Tou,Jingwei Zheng, Bicheng Chen, Sizhe Hu,Xiongfei Yu,Haohao Wang,Yimin Lu,Mei Kong,Yanyan Chen,Haiyong Wang,Haibin Zhang,Hongxia Xu, Fei Teng,Xian Shen,Nong Xu,Jian Ruan,Zhan Zhou, Jun Lu,Lisong Teng

Advanced science (Weinheim, Baden-Wurttemberg, Germany)pp.e03499-e03499, (2025)

Cited0Views0WOSBibtex

First-line Cadonilimab Plus Chemotherapy in HER2-negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Randomized, Double-Blind, Phase 3 Trial

Lin Shen,Yanqiao Zhang,Ziyu Li,Xiaotian Zhang,Xiangyu Gao,Bo Liu,Yusheng Wang,Yi Ba,Ning Li,Ruixing Zhang,Jingdong Zhang,Ye Chen,Jian Chen,Mingzhu Huang, Yang Fu, Mulin Liu,Zheng Liu,Jun Zhao,Wei Li,Jia Wei,Changzheng Li,Nong Xu,Zengqing Guo,Bangwei Cao,Lian Liu,Peng Nie,Lixin Wan, Lili Sheng,Zhenyang Liu,Yifu He,Kangsheng Gu,Guowu Wu,Weibo Wang, Futong Zhang,Wensheng Qiu,Jun Guo,Jieer Ying,Hongming Pan,Huiting Xu, Yuan,Yuansong Bai,Zhenghua Wang, Jiye Xu, Xuehong Zhao,Hao Liu,Xizhi Zhang,Wenxiang Dai, Hongyan Xu,Ming Liu, Lin Xie,Yong Tang,Jianying Jin,Xiujuan Qu,Xuefeng Fang,Mingwei Huang,Hao Chen,Zhendong Zheng,Ying Wang,Daqing Wang,Xiaoqin Li,Guohua Yu, Haiyan Liu,Yongjian Zhou,Diansheng Zhong,Shan Zeng,Mafei Kang, Meiqing Wang, Yong Gao, Wenxin Li,Zejun Wang, Minghui Zhang, Jinghua Zhang,Qingshan Li, Shujuan Sun,Aimin Zang,Lizhu Lin,Ming Xie,Zhixiang Zhuang,Tao Zhang,Zhifang Yao, Dongmei Lu,Wei Liu, Mingxiu Hu,Zhongmin Maxwell Wang,Baiyong Li,Michelle Xia, Jiajia Zhang,Xiangji Ying,Drew M. Pardoll,Jiafu Ji

Nature Medicinepp.1-8, (2025)

Cited1Views0WOSNATUREBibtex

Pembrolizumab in Patients of Chinese Descent with Microsatellite Instability-high/Mismatch Repair Deficient Advanced Solid Tumors: KEYNOTE-158 Final Analysis

Xiaohua Wu,Yimin Mao,Nong Xu,Yuxian Bai,Dong Wang,Xiaojun Chen,Xianli Yin,Yanhong Deng, Jianwei Yang,Jieqing Zhang,Jie Tang, Yi Huang,Jiayi Li,Suxia Luo, Hong Zheng, Weidong Zhao, Miaomiao Xu, Nan Li,Yixiang Mao,Alexander Gozman,Jianming Xu

Advances in Therapy（2025）

Cited0Views0WOSBibtex

Mecapegfilgrastim Prophylaxis for Neutropenia in Patients with Non-Myeloid Malignancies: A Chinese Nationwide Real-World Study

Shukui Qin,Yanxia Shi,Peifen Fu,Nong Xu,Chenyu Mao, Yong Chen,Yongsheng Wang,Huiqiang Huang,Xin Huang, Yongqing Li,Haijiao Yan, Yumin Yao, Gang Cheng,Zhe Yang,Ningling Zhang, Guifang Zhang,Minbin Chen, Hua Jiang,Zhangxia Ren, Liang Chen, Lifang Ding,Ruihua Xu,Jun Ma

BMC Cancerno. 1 (2025): 1-10

Cited0Views0WOSBibtex

Surufatinib in Advanced Neuroendocrine Tumours: Final Overall Survival from Two Randomised, Double-Blind, Placebo-Controlled Phase 3 Studies (Sanet-Ep and SANET-p)

Jianming Xu,Lin Shen,Jie Li,Zhiwei Zhou,Chunmei Bai,Zhiping Li,Yihebali Chi,Enxiao Li,Xianjun Yu,Nong Xu,Yuxian Bai,Xiuwen Wang,Xianglin Yuan,Tianshu Liu,Yongmei Yin,Jia Chen, Hanguang Hu,Xingya Li,Dianrong Xiu,Tao Zhang,Wenhui Lou,Jieer Ying,Shukui Qin,Yanhong Deng,Min Tao,Ying Cheng,Songhua Fan, Xian Luo, Xiaojun Guo, Michael M Shi,Weiguo Su

European journal of cancer (Oxford, England 1990) (2025): 115398-115398

Cited0Views0WOSBibtex

Phase Ib Study of the Oral PI3Kδ Inhibitor Linperlisib in Patients with Advanced Solid Tumors

Jin Li,Junli Xue,Tianshu Liu,Yi Feng,Nong Xu,Jianjin Huang,Yongmei Yin,Jun Zhang, Haibo Mou, Jiangzhong Shentu,Hanying Bao,Zusheng Xu,Zuhong Xu

International journal of clinical oncologyno. 2 (2024): 241-251

Cited0Views0WOSBibtex

Updated Safety and Antitumor Activity of BB-1701 from Study 101 in the Multiple Dose Level Cohort of Patients with Locally Advanced/metastatic HER2-low Expressing Breast Cancer

Fei Ma, Xiaoxiang Guan,Jingfen Wang,Herui Yao,Xian Wang,Erika P. Hamilton,Yehui Shi,Xinjun Liang,Nong Xu, Huoling Tang, Xiangzhu Tian, Yuhong Zhou,Ziping Wei,Pamela N. Munster

Journal of Clinical Oncologyno. 16_suppl (2024): 1110-1110

Cited0Views0Bibtex

New Techniques to Identify the Tissue of Origin for Cancer of Unknown Primary in the Era of Precision Medicine: Progress and Challenges

Wenyuan Ma,Hui Wu,Yiran Chen,Hongxia Xu,Junjie Jiang,Bang Du,Mingyu Wan,Xiaolu Ma,Xiaoyu Chen,Lili Lin,Xinhui Su,Xuanwen Bao,Yifei Shen,Nong Xu,Jian Ruan,Haiping Jiang,Yongfeng Ding

Briefings in bioinformaticsno. 2 (2024)

Cited7Views0EIWOSBibtex

Phase 1b/2 Study of Penpulimab (AK105), an Antiprogrammed Cell Death-1 Immunoglobulin G1 Antibody, in Advanced or Metastatic Solid Tumors (AK105-204)

Yulong Zheng,Jianqing Zhu,Jianping Xiong,Ou Jiang, Hong Wang,Yanru Xie,Yuefen Zhou,Nong Xu

Cancer（2024）

Cited1Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Nong Xu(徐农)

主任医师

Papers共 311 篇Author StatisticsCo-AuthorSimilar Experts